-
Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness.
Korthuis PT, Feaster DJ, Gomez ZL, Das M, Tross S, Wiest K, Douaihy AB, Mandler RN, Sorensen JL, Colfax GN, McCarty D, Cohen SE, Penn PE, Lape D, Metsche LR. Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness. Addictive Behaviors 2012;37(4):552-555.
-
Alcohol and drug dependence symptom items as brief screeners for substance use disorders: Results from the Clinical Trials Network.
Wu L, Blazer DG, Woody GE, Burchett B, Yang C, Pan J, Ling W. Alcohol and drug dependence symptom items as brief screeners for substance use disorders: Results from the Clinical Trials Network. Journal of Psychiatric Research 2012;46(3):360-369.
-
Integrating information on substance use disorders into electronic health record systems.
Tai B, McLellan AT. Integrating information on substance use disorders into electronic health record systems. Journal of Substance Abuse Treatment 2012;43(1):12-19.
-
Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.
Warden D, Trivedi MH, Greer TL, Nunes EV, Grannemann BD, Horigian VE, Somoza EC, Ring KM, Kyle T, Szapocznik J. Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse. Contemporary Clinical Trials 2012;33(1):29-37.
-
Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
Bini EJ, Kritz SA, Brown LS Jr, Robinson J, Calsyn D, Alderson D, Tracy K, McAuliffe P, Smith C, Rotrosen J. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States. Journal of Substance Abuse Treatment 2012;42(4):438–445.
-
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: An example from the NIDA Clinical Trials Network.
Campbell ANC, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen TJ, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: An example from the NIDA Clinical Trials Network. Contemporary Clinical Trials 2012;33(2):386-395.
-
Compensation effects on clinical trial data collection in opioid-dependent young adults.
Wilcox CE, Bogenschutz MP, Nakazawa M, Woody GE. Compensation effects on clinical trial data collection in opioid-dependent young adults. American Journal of Drug and Alcohol Abuse 2012;38(1):81-86.
-
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
Winhusen TJ, Stitzer M, Woody G, Brigham G, Kropp FB, Ghitza UE, Lindblad R, Adinoff B, Green C, Sharma G, Somoza E. Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. Contemporary Clinical Trials 2012;33(1):197-205.
-
Major depression and treatment response in adolescents with ADHD and substance use disorder.
Warden D, Riggs PD, Min S, Mikulich-Gilbertson SK, Tamm L, Trello-Rishel K, Winhusen TJ. Major depression and treatment response in adolescents with ADHD and substance use disorder. Drug and Alcohol Dependence 2012;120(1-3):214-219.
-
Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder.
Tamm L, Adinoff BH, Nakonezny PA, Winhusen TJ, Riggs PD. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. American Journal of Drug and Alcohol Abuse 2012;38(1):93-100.